Auf dieser Seite
01NATR Preis
02Momentaufnahme
03Chart
05Über uns
06Performance
07Bewertung & Kennzahlen
13Dividenden
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
26Meine Kennzahlen
NATR Nature's Sunshine Products, Inc. - Common Stock
NASDAQ · Consumer products · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$12,45
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$12,3252-Wochen-Tief
$28,1452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$219M
P/E (TTM)
12.3
EPS (TTM)
$1.01
Umsatz (TTM)
$492M
Ihre Abzeichen
52W-Spanne
$12–$28
Analystenbewertung
BUY
Kursziel
$30
P/E
12.3
ROE
10.9%
Nettogewinnmarge
3.7%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
NATR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$12.45
Marktkapitalisierung (MRQ)
$219M
P/E (TTM)
12.3
EPS (TTM)
$1.01
Umsatz (TTM)
$492M
ROE (TTM)
10.9%
52W-Spanne
$12–$28
NATR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Nature's Sunshine Products, Inc. - Common Stock Unternehmensübersicht von Wikipedia
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
History
Nature's Sunshine was founded in 1972 by Gene and Kristine Hughes, who started encapsulating capsicum in their home kitchen. The company employs a multi-level marketing business model in which their products are primarily sold to the consumer by independent distributors who receive commissions based on their own sales, as well as sign-up bonuses and commissions based upon the sales of any distributors they may have recruited.
NSP also owns Synergy Worldwide, a multi-level marketing company that also sells nutritional supplements. Products for both companies are manufactured in a production and research facility located in Spanish Fork, Utah.
In June 2021, Nature’s Sunshine Products, Inc. and the David Eccles School of Business at the University of Utah partnered together to create a new scholarship. Nature’s Sunshine Products, Inc. partnered with the Opportunity Scholars program to provide full-ride scholarships to underrepresented students who are the first in their family to attend college.
Like similar multilevel marketing companies, Nature's Sunshine's business has been adversely affected by the lingering effects of the COVID-19 pandemic, global inflation and the Russian invasion of Ukraine. In the 4th quarter of 2022, net sales fell 13% to $103 million, as compared to the 4th quarter of 2021. According to CEO Terrence Moorehead, the company is making "strategic changes" and "redesigning processes and revamping sourcing relationships."
SEC bribery lawsuit
In 2006, KPMG, which had provided auditing services to the company, resigned from the account. They charged that then-CEO Douglas Faggioli had lied to auditors about "alleged fraud," and had approved bribery. In July 2009, the company agreed to pay $600,000 in fines after being charged by the SEC with having bribed Brazilian officials with more than $1,000,000 in 2000 and 2001. This was done "so it could import unregistered nutritional products into the country, and then falsified its books to hide the payments."
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorConsumer products
BrancheConsumer products
Mitarbeiter806
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$480M2016-12-31 → 2025-12-31
EPS$1.062016-12-31 → 2025-12-31
Freier Cashflow$29M2016-12-31 → 2025-12-31
Nettogewinnmarge3.7%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | NATR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 12.35-Jahres-Durchschnitt ≈-64.7 | ≈-64.7 | · | · | |
| P/S (TTM) | 0.45-Jahres-Durchschnitt ≈0.7 | ≈0.7 | 1.2 | Unterbewertet | |
| K/B (MRQ) | 1.35-Jahres-Durchschnitt ≈1.9 | ≈1.9 | 2.4 | Fairer Wert | |
| Kurs / FCF (TTM) | 12.15-Jahres-Durchschnitt ≈6.5 | ≈6.5 | · | · | |
| Kurs / Cashflow (TTM) | 8.05-Jahres-Durchschnitt ≈52.7 | ≈52.7 | 16.5 | Unterbewertet | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.35-Jahres-Durchschnitt ≈1.9 | ≈1.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | NATR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 73.2%5-Jahres-Durchschnitt ≈72.2% | ≈72.2% | 69.0% | Spitzenklasse | |
| Betriebsgewinnmarge (TTM) | 6.0%5-Jahres-Durchschnitt ≈5.1% | ≈5.1% | -1.7% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 8.7%5-Jahres-Durchschnitt ≈7.8% | ≈7.8% | -1.6% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 5.8%5-Jahres-Durchschnitt ≈5.1% | ≈5.1% | -0.16% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 3.7%5-Jahres-Durchschnitt ≈3.2% | ≈3.2% | -0.52% | Spitzenklasse | |
| ROA (TTM) | 7.0%5-Jahres-Durchschnitt ≈5.9% | ≈5.9% | 3.5% | Spitzenklasse | |
| ROE (TTM) | 10.9%5-Jahres-Durchschnitt ≈9.3% | ≈9.3% | 12.8% | Im Einklang | |
| ROIC | 10.5%5-Jahres-Durchschnitt ≈9.2% | ≈9.2% | 3.6% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | NATR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 2.65-Jahres-Durchschnitt ≈2.3 | ≈2.3 | 2.6 | Im Einklang | |
| Quick Ratio | 1.35-Jahres-Durchschnitt ≈1.3 | ≈1.3 | 1.2 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | NATR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 5.7%5-Jahres-Durchschnitt ≈4.7% | ≈4.7% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 4.4%5-Jahres-Durchschnitt ≈3.4% | ≈3.4% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 4.5% | · | · | · | |
| EPS YoY (EPS VjV) | 165.0%5-Jahres-Durchschnitt ≈49.9% | ≈49.9% | · | · | |
| Net Income YoY (Nettogewinn YoY) | 153.7%5-Jahres-Durchschnitt ≈45.4% | ≈45.4% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -34.4% | · | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | -0.19% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -36.6% | · | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | -3.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | NATR | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 1.95-Jahres-Durchschnitt ≈1.8 | ≈1.8 | 1.3 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 2.15-Jahres-Durchschnitt ≈2.0 | ≈2.0 | 3.2 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 53.15-Jahres-Durchschnitt ≈46.6 | ≈46.6 | 32.9 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$595.7K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Annualisierte Auszahlung≈$4.00
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Mär 26, 2021 | $1,00 | USD | ≈5.5% |
| Mär 20, 2017 | $0,10 | USD | ≈4.0% |
| Nov 21, 2016 | $0,10 | USD | ≈2.6% |
| Aug 19, 2016 | $0,10 | USD | ≈3.1% |
| Mai 23, 2016 | $0,10 | USD | ≈4.4% |
| Mär 9, 2016 | $0,10 | USD | ≈4.4% |
| Nov 16, 2015 | $0,10 | USD | ≈3.7% |
| Aug 21, 2015 | $0,10 | USD | ≈14.7% |
| Mai 20, 2015 | $0,10 | USD | ≈14.7% |
| Mär 10, 2015 | $0,10 | USD | ≈16.7% |
| Nov 18, 2014 | $0,10 | USD | ≈13.1% |
| Sep 4, 2014 | $1,50 | USD | ≈13.2% |
| Aug 14, 2014 | $0,10 | USD | ≈13.2% |
| Mai 19, 2014 | $0,10 | USD | ≈14.4% |
| Mär 26, 2014 | $0,10 | USD | ≈14.4% |
| Mär 19, 2014 | $0,10 | USD | ≈13.6% |
| Nov 14, 2013 | $0,10 | USD | ≈10.6% |
| Aug 15, 2013 | $1,60 | USD | ≈10.5% |
| Mai 16, 2013 | $0,10 | USD | ≈2.0% |
| Mär 14, 2013 | $0,10 | USD | ≈1.7% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
57.6%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 6, 2026 | $0.21 | $0.28 | -23.7% |
| 31. März 2026 | Mai 12, 2026 | $0.30 | $0.23 | 30.7% |
| 31. Dezember 2025 | $0.30 | $0.19 | 54.8% | |
| 30. September 2025 | $0.36 | $0.16 | 120.6% | |
| 30. Juni 2025 | $0.35 | $0.16 | 114.5% | |
| 31. März 2025 | $0.25 | $0.17 | 48.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $480M | $454M | $445M | $422M | $444M | $385M | $362M | $365M | $342M | $341M | $325M | $366M | |
| Cost of Revenue | $132M | $130M | $124M | $122M | $115M | $101M | $94M | $96M | $91M | $91M | $85M | $92M | |
| Gross Profit | $348M | $325M | $321M | $300M | $329M | $284M | $268M | $269M | $251M | $250M | $239M | $275M | |
| R&D Expense | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | |
| SG&A Expense | $178M | $164M | $167M | $153M | $154M | $131M | $129M | $138M | $130M | $120M | $108M | $120M | |
| Operating Income | $25M | $20M | $19M | $16M | $35M | $21M | $16M | $5M | $1M | $10M | $14M | $19M | |
| Interest Expense | · | · | $69.0K | $249.0K | $250.0K | $102.0K | $43.0K | $387.0K | $289.0K | $16.0K | $130.0K | $187.0K | |
| Other Non-op | $5M | $-2M | $1M | $-1M | $-3M | $1M | $-483.0K | $-2M | $2M | $-773.0K | $-592.0K | $-34.0K | |
| Pretax Income | $30M | $18M | $20M | $15M | $32M | $23M | $16M | $3M | $3M | $9M | $13M | $19M | |
| Income Tax | $9M | $11M | $4M | $15M | $2M | $-137.0K | $9M | $4M | $17M | $9M | $2M | $-743.0K | |
| Net Income | $20M | $8M | $15M | $-390.0K | $30M | $23M | $7M | $-1M | $-14M | $675.0K | $14M | $10M | |
| EPS (Basic) | $1.08 | $0.41 | $0.79 | $-0.02 | $1.45 | $1.09 | $0.35 | $-0.04 | $-0.69 | $0.11 | $0.79 | $0.58 | |
| EPS (Diluted) | $1.06 | $0.40 | $0.77 | $-0.02 | $1.42 | $1.07 | $0.34 | $-0.04 | $-0.69 | $0.11 | $0.77 | $0.56 | |
| Shares (Basic) | 18,005,000 | 18,616,000 | 19,066,000 | 19,326,000 | 19,858,000 | 19,537,000 | 19,314,000 | 19,123,000 | 18,882,000 | 18,731,000 | 18,656,000 | 17,108,000 | |
| Shares (Diluted) | 18,468,000 | 19,089,000 | 19,466,000 | 19,326,000 | 20,327,000 | 19,968,000 | 19,663,000 | 19,123,000 | 18,882,000 | 19,056,000 | 19,177,000 | 17,641,000 | |
| EBITDA | $39M | $34M | $31M | $27M | $46M | · | $27M | $15M | $10M | $15M | $18M | $23M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $94M | $85M | $82M | $60M | $86M | $92M | $54M | $51M | $43M | $32M | $41M | $59M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $0 | $2M | $2M | $3M | |
| Receivables | $9M | $9M | $9M | $14M | $9M | $7M | $7M | $8M | $9M | $8M | $8M | $7M | |
| Inventory | $68M | $59M | $67M | $68M | $61M | $48M | $47M | $42M | $44M | $48M | $38M | $40M | |
| Prepaid Expense | $8M | $7M | $8M | $7M | $9M | $7M | $5M | $6M | $6M | $5M | $7M | $8M | |
| Current Assets | $179M | $161M | $166M | $150M | $165M | $154M | $113M | $107M | $103M | $95M | $102M | $121M | |
| PP&E (Net) | $33M | $40M | $45M | $46M | $51M | $54M | $60M | $64M | $69M | $73M | $69M | $51M | |
| PP&E (Gross) | $141M | $137M | $140M | $137M | $134M | $130M | $132M | $132M | $129M | $125M | $118M | $99M | |
| Accum. Depreciation | $108M | $98M | $95M | $91M | $83M | $76M | $73M | $68M | $60M | $52M | $49M | $48M | |
| Intangibles | · | · | · | · | · | · | $567.0K | $618.0K | $709.0K | $976.0K | $559.0K | $704.0K | |
| Other Non-current Assets | $11M | $9M | $10M | $10M | $10M | $11M | $11M | $11M | $13M | $14M | $11M | $8M | |
| Total Assets | $261M | $241M | $250M | $230M | $259M | $249M | $213M | $193M | $195M | $206M | $201M | $197M | |
| Accounts Payable | $8M | $9M | $8M | $6M | $10M | $6M | $4M | $5M | $4M | $5M | $6M | $5M | |
| Accrued Liabilities | $34M | $25M | $33M | $26M | $32M | $32M | $26M | $35M | $25M | $24M | $24M | $29M | |
| Short-term Debt | · | · | · | $1M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $79M | $66M | $77M | $66M | $77M | $70M | $58M | $67M | $54M | $63M | $53M | $58M | |
| Capital Leases | $16M | $10M | $10M | $14M | $16M | $16M | $20M | · | · | · | · | · | |
| Deferred Tax | $954.0K | $1M | $1M | $1M | $2M | $1M | $2M | $2M | $770.0K | $0 | $0 | $6.0K | |
| Other Non-current Liabilities | $3M | $1M | $644.0K | $1M | $1M | $1M | $1M | $705.0K | $1M | $2M | $2M | $2M | |
| Total Liabilities | $100M | $80M | $90M | $83M | $97M | $92M | $84M | $72M | $75M | $73M | $64M | $68M | |
| Long-term Debt | · | · | $0 | $1M | $2M | $4M | $0 | · | $13M | · | · | · | |
| Total Debt | · | · | $0 | $1M | $2M | · | · | · | $0 | $10M | $3M | · | |
| Common Stock | $102M | $115M | $120M | $122M | $133M | $139M | $136M | $134M | $132M | $130M | $127M | $125M | |
| Retained Earnings | $77M | $57M | $50M | $35M | $35M | $26M | $5M | $-2M | $-2M | $13M | $18M | $11M | |
| AOCI | $-18M | $-17M | $-15M | $-13M | $-10M | $-10M | $-11M | $-11M | $-10M | $-11M | $-11M | $-11M | |
| Stockholders' Equity | $162M | $161M | $160M | $147M | $161M | $157M | $129M | $121M | $120M | $132M | $136M | $129M | |
| Liabilities + Equity | $261M | $241M | $250M | $230M | $259M | $249M | $213M | $193M | $195M | $206M | $201M | $197M | |
| Shares Outstanding | 17,508,000 | 18,483,000 | 18,875,000 | 19,093,000 | 19,724,000 | 19,697,000 | 19,410,000 | 19,204,000 | 18,919,000 | 18,757,000 | 18,588,000 | 18,662,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $14M | $14M | $12M | $11M | $11M | $11M | $11M | $10M | $9M | $5M | $5M | $4M | |
| Stock-based Comp | $6M | $5M | $5M | $3M | $4M | $4M | $2M | $2M | $2M | $3M | $4M | $4M | |
| Deferred Tax | $-2M | $-2M | $-8M | $8M | $-4M | $-4M | $4M | $-76.0K | $14M | $761.0K | $-3M | $-4M | |
| Amort. of Intangibles | · | · | · | · | · | · | $100.0K | $100.0K | $200.0K | $100.0K | $100.0K | $100.0K | |
| Restructuring | · | · | · | · | $417.0K | $808.0K | $2M | $2M | $1M | $200.0K | $200.0K | $3M | |
| Other Non-cash | $-2M | $257.0K | $17M | $-22M | $-6M | · | $-15M | $11M | $-645.0K | $-6M | $-9M | $108.0K | |
| Operating Cash Flow | $35M | $25M | $41M | $710.0K | $35M | $38M | $9M | $22M | $11M | $3M | $10M | $14M | |
| CapEx | $6M | $11M | $10M | $8M | $7M | $5M | $5M | $5M | $6M | $11M | $23M | $26M | |
| Investing Cash Flow | $-6M | $-11M | $-10M | $-8M | $-7M | $-5M | $-5M | $211.0K | $-3M | $-12M | $-19M | $-27M | |
| Debt Issued | · | · | · | · | · | · | · | $68M | $19M | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | $-13M | $13M | $0 | $0 | $-12M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $4M | |
| Stock Repurchased | $16M | $9M | $6M | $14M | $7M | $0 | · | · | $0 | $0 | $7M | $7M | |
| Net Stock Activity | $-16M | $-9M | $-6M | $-14M | $-7M | · | · | · | $0 | $0 | $-7M | $-3M | |
| Dividends Paid | · | · | · | $0 | $20M | $0 | · | $0 | $2M | $8M | $7M | $35M | |
| Financing Cash Flow | $-24M | $-10M | $-8M | $-16M | $-32M | $4M | $-63.0K | $-12M | $2M | $-286.0K | $-8M | $-5M | |
| Net Change in Cash | $9M | $2M | $22M | $-26M | $-6M | $38M | $3M | $8M | $11M | $-9M | $-17M | $-19M | |
| Taxes Paid | $13M | $15M | $9M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $29M | $14M | $31M | $-7M | $28M | · | $3M | $17M | $5M | $-8M | $-12M | $-12M | |
| Levered FCF | · | · | $31M | $-7M | $28M | · | $3M | $17M | $6M | $-8M | $-12M | $-12M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 72.4% | 71.5% | 72.1% | 71.0% | 74.0% | · | 74.1% | 73.8% | 73.4% | 73.3% | 73.7% | 75.0% | |
| Operating Margin | 5.1% | 4.4% | 4.2% | 3.9% | 7.8% | · | 4.5% | 1.5% | 0.41% | 2.9% | 4.3% | 5.2% | |
| Net Margin | 4.1% | 1.7% | 3.4% | 0.13% | 6.8% | · | 1.9% | -0.33% | -4.0% | 0.20% | 4.2% | 2.7% | |
| Pretax Margin | 6.2% | 4.1% | 4.5% | 3.6% | 7.2% | · | 4.3% | 0.88% | 0.94% | 2.7% | 4.1% | 5.2% | |
| EBITDA Margin | 8.0% | 7.5% | 6.9% | 6.5% | 10.3% | · | 7.4% | 4.2% | 2.9% | 4.3% | 5.7% | 6.4% | |
| ROA | 7.8% | 3.1% | 6.3% | 0.23% | 11.9% | · | 3.4% | -0.62% | -6.9% | 0.33% | 6.9% | 4.9% | |
| ROE | 12.0% | 4.8% | 9.7% | 0.38% | 19.6% | · | 5.4% | -1.0% | -11.0% | 0.50% | 10.3% | 8.4% | |
| ROIC | 10.5% | 5.3% | 9.6% | 0.40% | 20.1% | · | 5.5% | -1.7% | -5.0% | 0.51% | 8.7% | 15.3% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.4 | 2.2 | 2.3 | 2.1 | · | 1.9 | 1.6 | 1.9 | 1.6 | 1.9 | 2.1 | |
| Quick Ratio | 1.3 | 1.4 | 1.2 | 1.1 | 1.2 | · | 1.1 | 0.9 | 1.0 | 0.7 | 1.0 | 1.2 | |
| Debt / Equity | · | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.0 | 0.1 | 0.0 | · | |
| LT Debt / Equity | · | · | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | 271.7 | 65.3 | 138.7 | · | 375.0 | 13.8 | 4.8 | 627.4 | 106.7 | 101.9 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.9 | 1.9 | 1.9 | 1.7 | 1.7 | · | 1.8 | 1.9 | 1.7 | 1.7 | 1.6 | 1.8 | |
| Inventory Turnover | 2.1 | 2.1 | 1.8 | 1.9 | 2.1 | · | 2.1 | 2.2 | 2.0 | 2.1 | 2.2 | 2.2 | |
| Receivables Turnover | 53.1 | 49.6 | 38.8 | 36.7 | 54.7 | · | 48.1 | 43.9 | 41.1 | 44.2 | 45.0 | 43.3 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $9.23 | $8.71 | $8.45 | $7.70 | $8.18 | · | $6.67 | $6.28 | $6.33 | $7.06 | $7.33 | $6.91 | |
| Revenue / Share | $26.00 | $23.80 | $22.88 | $21.83 | $21.85 | · | $18.42 | $19.08 | $18.11 | $17.90 | $16.93 | $20.77 | |
| Cash Flow / Share | $1.91 | $1.33 | $2.12 | $0.04 | $1.70 | · | $0.43 | $1.14 | $0.56 | $0.18 | $0.53 | $0.80 | |
| Cash / Share | $5.36 | $4.58 | $4.36 | $3.14 | $4.37 | · | $2.76 | $2.64 | $2.27 | $1.72 | $2.23 | $3.15 | |
| Dividend / Share | · | · | · | $0.00 | $1.00 | $0.00 | $0.00 | $0.00 | $0.10 | $0.40 | $0.40 | $1.90 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | $0.10 | $0.40 | $0.40 | $1.90 | |
| EPS (TTM) | $1.06 | $0.40 | $0.77 | $-0.02 | $1.42 | $1.07 | $0.34 | $-0.04 | $-0.69 | $0.11 | $0.77 | $0.56 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.7% | 2.0% | 5.5% | -5.0% | 15.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.4% | 0.77% | 5.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 4.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 165.0% | -48.0% | · | · | 32.7% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -34.4% | -10.4% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -0.19% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 153.7% | -48.9% | · | · | 31.6% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -36.6% | -13.1% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -3.2% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $480M | $454M | $445M | $422M | $444M | $385M | $362M | $365M | $342M | $341M | $325M | $366M | |
| Net Income TTM | $20M | $8M | $15M | $-390.0K | $30M | $23M | $7M | $-1M | $-14M | $675.0K | $14M | $10M | |
| Market Cap | $378M | $271M | $326M | $159M | $365M | · | $173M | $157M | $219M | $281M | $188M | $277M | |
| Enterprise Value | · | · | $244M | $100M | $281M | · | · | · | $176M | $257M | $148M | · | |
| P/E | 20.4 | 36.6 | 22.5 | -416.0 | 13.0 | 14.0 | 26.3 | -203.8 | -16.7 | 136.4 | 13.1 | 26.5 | |
| P/S | 0.8 | 0.6 | 0.7 | 0.4 | 0.8 | · | 0.5 | 0.4 | 0.6 | 0.8 | 0.6 | 0.8 | |
| P/B | 2.3 | 1.7 | 2.0 | 1.1 | 2.3 | · | 1.3 | 1.3 | 1.8 | 2.1 | 1.4 | 2.1 | |
| P / Tangible Book | 2.3 | 1.7 | 2.0 | 1.1 | 2.3 | 1.9 | · | · | · | · | · | · | |
| P / Cash Flow | 10.7 | 10.7 | 7.9 | 223.7 | 10.5 | · | 20.3 | 7.2 | 20.8 | 82.3 | 18.5 | 19.5 | |
| P / FCF | 13.1 | 18.9 | 10.6 | -23.0 | 13.1 | · | 50.4 | 9.2 | 43.5 | -37.0 | -15.2 | -22.9 | |
| EV / EBITDA | · | · | 8.0 | 3.7 | 6.1 | · | · | · | 17.5 | 17.3 | 8.0 | · | |
| EV / FCF | · | · | 7.9 | -14.5 | 10.1 | · | · | · | 35.0 | -33.8 | -11.9 | · | |
| EV / Revenue | · | · | 0.5 | 0.2 | 0.6 | · | · | · | 0.5 | 0.8 | 0.5 | · | |
| Dividend Yield | · | · | · | 0.00% | 5.4% | · | · | 0.00% | 0.85% | 2.7% | 4.0% | 12.7% | |
| Earnings Yield | 4.9% | 2.7% | 4.5% | -0.24% | 7.7% | 7.2% | 3.8% | -0.49% | -6.0% | 0.73% | 7.6% | 3.8% | |
| Payout Ratio | · | · | · | 0.00% | 65.7% | · | · | 0.00% | -13.4% | 1112.4% | 54.9% | 359.5% | |
| Annual Payout | · | · | · | $0 | $20M | $0 | · | $0 | $2M | $8M | $7M | $35M |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $117M | $123M | $124M | $128M | $115M | $113M | $118M | $115M | $111M | $111M | $109M | $111M | $117M | $109M | $103M | $105M | |
| Cost of Revenue | $31M | $33M | $34M | $34M | $32M | $32M | $33M | $33M | $32M | $32M | $31M | $30M | $32M | $32M | $29M | $30M | |
| Gross Profit | $86M | $90M | $90M | $94M | $82M | $82M | $85M | $82M | $79M | $79M | $78M | $81M | $85M | $77M | $74M | $75M | |
| SG&A Expense | $45M | $44M | $48M | $46M | $44M | $41M | $44M | $41M | $39M | $41M | $40M | $41M | $42M | $44M | $39M | $37M | |
| Operating Income | $5M | $10M | $5M | $9M | $4M | $6M | $5M | $5M | $6M | $5M | $6M | $6M | $7M | $172.0K | $4M | $5M | |
| Other Non-op | $-115.0K | $-1M | $165.0K | $697.0K | $3M | $937.0K | $-3M | $3M | $-1M | $31.0K | $2M | $-927.0K | $-1M | $2M | $2M | $-2M | |
| Pretax Income | $5M | $8M | $5M | $10M | $8M | $7M | $1M | $8M | $4M | $5M | $8M | $5M | $6M | $2M | $6M | $3M | |
| Income Tax | $2M | $3M | $974.0K | $4M | $2M | $2M | $2M | $3M | $3M | $2M | $-2M | $2M | $3M | $433.0K | $4M | $3M | |
| Net Income | $4M | $5M | $4M | $5M | $5M | $5M | $-321.0K | $4M | $1M | $2M | $9M | $3M | $2M | $860.0K | $2M | $90.0K | |
| EPS (Basic) | $0.20 | $0.29 | $0.23 | $0.30 | $0.29 | $0.26 | $-0.01 | $0.23 | $0.07 | $0.12 | $0.46 | $0.15 | $0.13 | $0.05 | $0.10 | $0.00 | |
| EPS (Diluted) | $0.19 | $0.29 | $0.23 | $0.30 | $0.28 | $0.25 | $-0.02 | $0.23 | $0.07 | $0.12 | $0.46 | $0.15 | $0.12 | $0.04 | $0.10 | $0.00 | |
| Shares (Basic) | 17,812,000 | 17,522,000 | · | 17,638,000 | 18,406,000 | 18,486,000 | · | 18,512,000 | 18,647,000 | 18,828,000 | · | 19,133,000 | 19,293,000 | 19,061,000 | · | 19,198,000 | |
| Shares (Diluted) | 18,337,000 | 17,929,000 | · | 18,034,000 | 18,966,000 | 18,846,000 | · | 18,890,000 | 19,119,000 | 19,224,000 | · | 19,492,000 | 19,747,000 | 19,433,000 | · | 19,482,000 | |
| EBITDA | $5M | $13M | · | $9M | $4M | $10M | · | $5M | $6M | $8M | · | $6M | $7M | $3M | · | $5M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $83M | $88M | $94M | $96M | $81M | $86M | $85M | $79M | $69M | $78M | $82M | $76M | $69M | $66M | $60M | $57M | |
| Receivables | $14M | $13M | $9M | $15M | $13M | $11M | $9M | $11M | $11M | $10M | $9M | $9M | $12M | $10M | $14M | $10M | |
| Inventory | $72M | $67M | $68M | $67M | $69M | $65M | $59M | $62M | $62M | $63M | $67M | $66M | $66M | $68M | $68M | $68M | |
| Prepaid Expense | $10M | $11M | $8M | $8M | $8M | $8M | $7M | $11M | $10M | $10M | $8M | $8M | $9M | $11M | $7M | $8M | |
| Current Assets | $178M | $179M | $179M | $186M | $172M | $171M | $161M | $164M | $152M | $160M | $166M | $160M | $156M | $154M | $150M | $143M | |
| PP&E (Net) | $31M | $31M | $33M | $34M | $36M | $38M | $40M | $42M | $45M | $45M | $45M | $46M | $45M | $46M | $46M | $47M | |
| PP&E (Gross) | · | · | $141M | · | · | · | $137M | · | · | · | $140M | · | · | · | $137M | · | |
| Accum. Depreciation | · | · | $108M | · | · | · | $98M | · | · | · | $95M | · | · | · | $91M | · | |
| Other Non-current Assets | $10M | $10M | $11M | $10M | $10M | $10M | $9M | $10M | $10M | $10M | $10M | $9M | $10M | $10M | $10M | $9M | |
| Total Assets | $260M | $261M | $261M | $265M | $255M | $253M | $241M | $245M | $236M | $247M | $250M | $240M | $236M | $235M | $230M | $224M | |
| Accounts Payable | $8M | $8M | $8M | $7M | $10M | $10M | $9M | $9M | $8M | $9M | $8M | $7M | $7M | $9M | $6M | $7M | |
| Accrued Liabilities | $26M | $25M | $34M | $31M | $27M | $25M | $25M | $24M | $23M | $23M | $33M | $32M | $29M | $29M | $26M | $25M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $216.0K | $537.0K | · | · | · | |
| Current Liabilities | $69M | $71M | $79M | $84M | $76M | $71M | $66M | $67M | $64M | $69M | $77M | $73M | $71M | $72M | $66M | $64M | |
| Capital Leases | $17M | $18M | $16M | $10M | $11M | $11M | $10M | $11M | $11M | $13M | $10M | $11M | $13M | $13M | $14M | $14M | |
| Deferred Tax | $886.0K | $799.0K | $954.0K | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $1M | $936.0K | $1M | $1M | |
| Other Non-current Liabilities | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $1M | $983.0K | $644.0K | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $91M | $95M | $100M | $98M | $91M | $86M | $80M | $83M | $79M | $88M | $90M | $88M | $87M | $88M | $83M | $82M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $2M | · | · | · | · | · | · | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $216.0K | $537.0K | · | · | · | |
| Common Stock | $101M | $102M | $102M | $104M | $105M | $115M | $115M | $114M | $114M | $119M | $120M | $123M | $123M | $122M | $122M | $121M | |
| Retained Earnings | $86M | $82M | $77M | $73M | $67M | $62M | $57M | $58M | $53M | $52M | $50M | $41M | $38M | $35M | $35M | $33M | |
| AOCI | $-17M | $-17M | $-18M | $-16M | $-14M | $-16M | $-17M | $-15M | $-17M | $-17M | $-15M | $-17M | $-16M | $-15M | $-13M | $-16M | |
| Stockholders' Equity | $169M | $167M | $162M | $167M | $164M | $167M | $161M | $163M | $156M | $160M | $160M | $152M | $149M | $147M | $147M | $142M | |
| Liabilities + Equity | $260M | $261M | $261M | $265M | $255M | $253M | $241M | $245M | $236M | $247M | $250M | $240M | $236M | $235M | $230M | $224M | |
| Shares Outstanding | 17,614,000 | 17,564,000 | 17,508,000 | 17,560,000 | 17,635,000 | 18,474,000 | 18,483,000 | 18,498,000 | 18,508,000 | 18,786,000 | 18,875,000 | 19,097,000 | 19,098,000 | 19,045,000 | 19,093,000 | 19,166,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $4M | $4M | $3M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $950.0K | $1M | $1M | $1M | $1M | $1M | $1M | $967.0K | $593.0K | |
| Deferred Tax | $-30.0K | $677.0K | $-169.0K | $1M | $-1M | $-2M | $-2M | $40.0K | $143.0K | $-157.0K | $-5M | $-663.0K | $-2M | $-631.0K | $2M | $629.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $100.0K | |
| Other Non-cash | · | $-13M | · | · | · | $-5M | · | · | · | $-5M | · | · | · | $5M | · | · | |
| Operating Cash Flow | $835.0K | $-2M | $10M | $18M | $4M | $3M | $12M | $10M | $1M | $2M | $10M | $14M | $8M | $9M | $4M | $6M | |
| CapEx | $3M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $3M | $4M | $1M | $4M | $2M | $2M | $3M | $973.0K | |
| Investing Cash Flow | $-3M | $-2M | $-2M | $-2M | $-1M | $-1M | $-2M | $-2M | $-3M | $-4M | $-1M | $-4M | $-2M | $-2M | $-3M | $-973.0K | |
| Stock Repurchased | $2M | $500.0K | $2M | $2M | $12M | $476.0K | $423.0K | $711.0K | $6M | $2M | $4M | $1M | $97.0K | $823.0K | $626.0K | $974.0K | |
| Net Stock Activity | · | $-500.0K | · | · | · | $-476.0K | · | · | · | $-2M | · | · | · | $-823.0K | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Financing Cash Flow | $-3M | $-2M | $-9M | $-2M | $-12M | $-731.0K | $-576.0K | $-1M | $-8M | $107.0K | $-5M | $-2M | $-657.0K | $-1M | $-941.0K | $-1M | |
| Net Change in Cash | $-5M | $-6M | $-2M | $14M | $-5M | $2M | $6M | $10M | $-9M | $-5M | $6M | $7M | $3M | $6M | $3M | $640.0K | |
| Taxes Paid | $4M | $2M | $5M | $1M | $4M | $2M | $5M | $2M | $7M | $1M | $2M | $2M | $3M | $2M | · | $-787.0K | |
| Free Cash Flow | · | $-4M | · | · | · | $1M | · | · | · | $-1M | · | · | · | $7M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.7% | 73.2% | · | 73.3% | 71.7% | 72.0% | · | 71.3% | 71.4% | 71.2% | · | 73.0% | 72.6% | 70.8% | · | 71.7% | |
| Operating Margin | 4.7% | 7.8% | · | 7.0% | 3.7% | 5.5% | · | 4.6% | 5.1% | 4.2% | · | 5.2% | 6.0% | 0.16% | · | 4.8% | |
| Net Margin | 3.0% | 4.2% | · | 4.2% | 4.7% | 4.2% | · | 3.8% | 1.2% | 2.1% | · | 2.5% | 2.1% | 0.79% | · | 0.09% | |
| Pretax Margin | 4.6% | 6.6% | · | 7.5% | 6.6% | 6.3% | · | 6.9% | 4.0% | 4.2% | · | 4.4% | 5.1% | 1.6% | · | 2.6% | |
| EBITDA Margin | 4.7% | 10.4% | · | 7.0% | 3.7% | 8.5% | · | 4.6% | 5.1% | 7.0% | · | 5.2% | 6.0% | 2.7% | · | 4.8% | |
| ROA | 1.4% | 2.0% | · | 2.1% | 2.2% | 1.9% | · | 1.8% | 0.57% | 0.96% | · | 1.2% | 1.0% | 0.36% | · | 0.04% | |
| ROE | 2.1% | 3.1% | · | 3.2% | 3.3% | 2.9% | · | 2.8% | 0.88% | 1.5% | · | 1.9% | 1.7% | 0.58% | · | 0.06% | |
| ROIC | 2.1% | 3.6% | · | 3.1% | 1.9% | 2.5% | · | 1.9% | 1.2% | 1.6% | · | 2.5% | 2.1% | 0.09% | · | 0.26% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 2.5 | · | 2.2 | 2.3 | 2.4 | · | 2.4 | 2.4 | 2.3 | · | 2.2 | 2.2 | 2.2 | · | 2.2 | |
| Quick Ratio | 1.4 | 1.4 | · | 1.3 | 1.2 | 1.4 | · | 1.3 | 1.3 | 1.3 | · | 1.2 | 1.1 | 1.1 | · | 1.0 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | · | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Inventory Turnover | 0.4 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.7 | 10.3 | · | 9.7 | 9.4 | 10.7 | · | 11.0 | 9.3 | 11.0 | · | 11.4 | 10.1 | 12.2 | · | 10.9 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $9.61 | $9.50 | · | $9.49 | $9.28 | $9.05 | · | $8.79 | $8.45 | $8.50 | · | $7.96 | $7.82 | $7.70 | · | $7.40 | |
| Revenue / Share | $6.38 | $6.85 | · | $7.12 | $6.05 | $6.01 | · | $6.07 | $5.78 | $5.77 | · | $5.71 | $5.90 | $5.59 | · | $5.36 | |
| Cash Flow / Share | · | $-0.10 | · | · | · | $0.14 | · | · | · | $0.11 | · | · | · | $0.48 | · | · | |
| Cash / Share | $4.68 | $4.99 | · | $5.44 | $4.61 | $4.68 | · | $4.25 | $3.71 | $4.14 | · | $3.98 | $3.61 | $3.45 | · | $2.97 | |
| Dividend / Share | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0.00 | |
| EPS (TTM) | $1.01 | $1.10 | · | $0.81 | $0.74 | $0.53 | · | $0.88 | $0.80 | $0.85 | · | $0.41 | $0.26 | $0.17 | · | $0.54 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $492M | $490M | · | $475M | $461M | $457M | · | $445M | $442M | $448M | · | $439M | $432M | $420M | · | $437M | |
| Net Income TTM | $18M | $20M | · | $15M | $14M | $10M | · | $17M | $15M | $17M | · | $8M | $5M | $3M | · | $12M | |
| Market Cap | $384M | $421M | · | $273M | $261M | $232M | · | $252M | $279M | $390M | · | $316M | $261M | $194M | · | $158M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $241M | $192M | · | · | · | |
| P/E | 21.6 | 21.8 | · | 19.2 | 20.0 | 23.7 | · | 15.5 | 18.8 | 24.4 | · | 40.4 | 52.5 | 60.1 | · | 15.3 | |
| P/S | 0.8 | 0.9 | · | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.6 | 0.9 | · | 0.7 | 0.6 | 0.5 | · | 0.4 | |
| P/B | 2.3 | 2.5 | · | 1.6 | 1.6 | 1.4 | · | 1.5 | 1.8 | 2.4 | · | 2.1 | 1.7 | 1.3 | · | 1.1 | |
| P / Tangible Book | 2.3 | 2.5 | · | 1.6 | 1.6 | 1.4 | · | 1.5 | 1.8 | 2.4 | · | 2.1 | 1.7 | 1.3 | · | 1.1 | |
| P / Cash Flow | · | -228.3 | · | · | · | 88.9 | · | · | · | 178.2 | · | · | · | 20.9 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 0.5 | 0.4 | · | · | · | |
| Earnings Yield | 4.6% | 4.6% | · | 5.2% | 5.0% | 4.2% | · | 6.5% | 5.3% | 4.1% | · | 2.5% | 1.9% | 1.7% | · | 6.6% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $480M | $454M | $445M | $422M | $444M |
| Bruttogewinnmarge % | 72.4% | 71.5% | 72.1% | 71.0% | 74.0% |
| Betriebsgewinnmarge % | 5.1% | 4.4% | 4.2% | 3.9% | 7.8% |
| Nettoergebnis | $20M | $8M | $15M | $-390.0K | $30M |
| Verwässerte EPS | $1.06 | $0.40 | $0.77 | $-0.02 | $1.42 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | · | 0.0 | 0.0 | 0.0 |
| Liquiditätsgrad | 2.3 | 2.4 | 2.2 | 2.3 | 2.1 |
| Quick Ratio | 1.3 | 1.4 | 1.2 | 1.1 | 1.2 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $29M | $14M | $31M | $-7M | $28M |
Institutionelle Eigentümer (13F) 160 Einreicher · $346.1M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
160
Gehaltener Wert
$346.1M
Neue Positionen
19
Geschlossene Positionen
15
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 19 (-14 vs. Vorquartal) | 15 (-7 vs. Vorquartal) | 52 (-6 vs. Vorquartal) | 52 (+19 vs. Vorquartal) | +606K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| WYNNEFIELD CAPITAL INC | $53.926.354 | 2.473.686 | 15,58% | Aktien |
| Prescott Group Capital Management, L.L.C. | $38.871.516 | 1.783.097 | 11,23% | Aktien |
| BlackRock, Inc. | $21.560.637 | 989.020 | 6,23% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $20.134.573 | 923.626 | 5,82% | Aktien |
| VANGUARD GROUP INC | $17.342.227 | 803.625 | 5,01% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $15.583.272 | 714.829 | 4,50% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $13.599.516 | 623.831 | 3,93% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $13.176.160 | 604.411 | 3,81% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $11.500.982 | 527.568 | 3,32% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $8.284.221 | 379.914 | 2,39% | Aktien |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | $7.412.000 | 340.000 | 2,14% | Aktien |
| STATE STREET CORP | $7.126.202 | 326.890 | 2,06% | Aktien |
| Hillsdale Investment Management Inc. | $6.640.433 | 304.607 | 1,92% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.309.094 | 289.408 | 1,82% | Aktien |
| Boston Partners | $5.726.060 | 262.663 | 1,65% | Aktien |
| MORGAN STANLEY | $5.133.708 | 235.491 | 1,48% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $4.669.320 | 214.189 | 1,35% | Aktien |
| Nuveen, LLC | $4.553.846 | 208.892 | 1,32% | Aktien |
| BFSG, LLC | $4.335.170 | 198.861 | 1,25% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $4.169.272 | 191.251 | 1,20% | Aktien |
| JPMORGAN CHASE & CO | $4.048.623 | 187.784 | 1,17% | Aktien |
| MACKENZIE FINANCIAL CORP | $3.141.467 | 144.104 | 0,91% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.891.639 | 132.644 | 0,84% | Aktien |
| NORTHERN TRUST CORP | $2.831.536 | 129.887 | 0,82% | Aktien |
| Man Group plc | $2.765.831 | 126.873 | 0,80% | Aktien |
| ALGERT GLOBAL LLC | $2.700.911 | 123.895 | 0,78% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $2.427.365 | 111.347 | 0,70% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $2.365.758 | 108.521 | 0,68% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $2.211.239 | 101.433 | 0,64% | Aktien |
| North Star Investment Management Corp. | $2.170.190 | 99.550 | 0,63% | Aktien |
| First Eagle Investment Management, LLC | $2.153.840 | 98.800 | 0,62% | Aktien |
| AMERIPRISE FINANCIAL INC | $2.126.065 | 97.526 | 0,61% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.091.601 | 95.945 | 0,60% | Aktien |
| GOLDMAN SACHS GROUP INC | $1.780.645 | 81.681 | 0,51% | Aktien |
| SEI INVESTMENTS CO | $1.597.506 | 73.280 | 0,46% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $1.487.959 | 68.255 | 0,43% | Aktien |
| PRUDENTIAL FINANCIAL INC | $1.435.029 | 65.827 | 0,41% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1.318.944 | 60.502 | 0,38% | Aktien |
| Aristides Capital LLC | $1.313.363 | 60.246 | 0,38% | Aktien |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $1.303.335 | 59.786 | 0,38% | Aktien |
| SummerHaven Investment Management, LLC | $1.088.714 | 49.941 | 0,31% | Aktien |
| Trexquant Investment LP | $1.037.811 | 47.606 | 0,30% | Aktien |
| FIRST TRUST ADVISORS LP | $1.030.551 | 47.273 | 0,30% | Aktien |
| Bank of New York Mellon Corp | $1.024.165 | 46.980 | 0,30% | Aktien |
| FMR LLC | $1.007.362 | 46.209 | 0,29% | Aktien |
| FRANKLIN RESOURCES INC | $1.002.125 | 45.969 | 0,29% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $974.896 | 44.720 | 0,28% | Aktien |
| Russell Investments Group, Ltd. | $954.632 | 43.867 | 0,28% | Aktien |
| TWO SIGMA ADVISERS, LP | $820.040 | 38.000 | 0,24% | Aktien |
| Invesco Ltd. | $818.329 | 37.538 | 0,24% | Aktien |
Aktivisten & 5%+-Eigentümer 7 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Fosun Pharma USA Inc. ×4 Einreichungen | 27. Juni 2025 | 0,35% | Änderung | Kapitalstruktur | SEC |
| Red Mountain Capital Partners LLC, Red Mountain Partners, L.P., RMCP GP LLC, Red Mountain Capital Management, Inc., Willem Mesdag ×11 Einreichungen | 20. September 2021 | · | Erste Einreichung | · | SEC |
| Prescott Group Capital Management, L.L.C., Prescott Group Aggressive Small Cap, L.P., Prescott Group Aggressive Small Cap II, L.P., Prescott Group Aggressive Small Cap Master Fund, G.P., Phil Frohlich ×4 Einreichungen | 21. Oktober 2020 | · | Erste Einreichung | Vorstandskampagne | SEC |
| Wynnefield Partners Small Cap Value, L.P. I, Wynnefield Partners Small Cap Value, L.P., Wynnefield Small Cap Value Offshore Fund, Ltd. (No IRS Identification No.), Wynnefield Capital, Inc. Profit Sharing & Money Purchase Plan, Wynnefield Capital Management, LLC, Wynnefield Capital, Inc., Nelson Obus, Joshua Landes | 12. Juni 2017 | · | Erste Einreichung | Vorstandskampagne | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 10. März 2010 | · | Erste Einreichung | · | SEC |
| Paradigm Capital Management, Inc., Candace K. Weir | 29. Mai 2009 | · | Erste Einreichung | Vorstandskampagne | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 28. Mai 2009 | · | Erste Einreichung | Vorstandskampagne | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 58 Insider · 25 Führungskräfte · 27 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kenneth G. Romanzi | Chief Executive Officer | 15. Mai 2026 A | 143.999 | 0 | 0 | $0 |
| Terrence Moorehead | Chief Executive Officer | 21. Juli 2025 F | 543.292 | 0 | 0 | $0 |
| Michael Dean | President and CEO | 1. März 2012 A | 4.000 | 0 | 0 | $0 |
| Douglas Faggioli | President and CEO | 12. Mai 2010 M | 114.436 | 0 | 0 | $0 |
| Ruth Ann Perkins | EVP, Chief Financial Officer | 2. September 2026 A | 75.433 | 0 | 0 | $0 |
| Leslie Shane Jones | EVP & Chief Financial Officer | 5. Mai 2026 F | 104.658 | 0 | 0 | $0 |
| Joseph W Baty | EVP & Chief Financial Officer | 21. Juli 2022 A | 173.702 | 0 | 0 | $0 |
| Craig D Huff | EVP & CFO | 10. August 2005 M | 7.000 | 0 | 0 | $0 |
| Jonathan David Lanoy | SVP, Chief Accounting Officer | 1. September 2026 A | 55.602 | 0 | 2 | $-201.050 |
| Kevin R. Herbert | EVP & President, North America | 26. Juni 2026 F | 46.890 | 0 | 2 | $-41.364 |
| Bryant J Yates | EVP & President, Europe | 5. Juni 2026 S | 77.446 | 0 | 3 | $-751.271 |
| Daniel C Norman | EVP & President, Asia | 1. Juni 2026 S | 47.276 | 0 | 3 | $-759.434 |
| Nathan G Brower | EVP, General Counsel | 21. Mai 2026 S | 43.438 | 0 | 2 | $-341.486 |
| Kevin Gregory Fuller | Global Chief Marketing Officer | 15. Mai 2026 A | 31.548 | 0 | 0 | $0 |
| Erich A Fritz | EVP, Global Supply Chain | 15. Mai 2026 A | 20.889 | 0 | 0 | $0 |
| Martin A. Gonzalez | EVP, Global Supply Chain | 4. November 2025 F | 69.640 | 0 | 0 | $0 |
| Tracee Comstock | VP, Human Resources | 21. Juli 2025 F | 64.449 | 0 | 0 | $0 |
| Sarah Crockett | Global Chief Marketing Officer | 11. März 2024 A | 26.873 | 0 | 0 | $0 |
| Edward Silcock | EVP & President, North America | 21. Juli 2022 A | 51.486 | 0 | 0 | $0 |
| Susan M Armstrong | EVP & Chief Operations Officer | 12. Februar 2019 F | 37.651 | 0 | 0 | $0 |
| Richard Strulson | EVP/Gen. Counsel/CCO | 11. Februar 2017 F | 27.140 | 0 | 0 | $0 |
| Matthew L Tripp | EVP & Chief Scientific Officer | 2. März 2015 F | 13.987 | 0 | 0 | $0 |
| Jamon Jarvis | EVP, Gen Counsel, Sec, CCO | 30. August 2013 M | 0 | 0 | 0 | $0 |
| Daren G Hogge | EVP, President - Int'l. Div. | 22. November 2004 M | 0 | 0 | 0 | $0 |
| Dale G Lee | EVP & President US Sales | 27. Mai 2004 M | 3.005 | 0 | 0 | $0 |
| Rong Yang | Direktor | 15. Mai 2026 A | 34.749 | 0 | 0 | $0 |
| Tess Roering | Direktor | 15. Mai 2026 A | 34.427 | 0 | 0 | $0 |
| Curtis Kopf | Direktor | 15. Mai 2026 A | 34.427 | 0 | 0 | $0 |
| Heidi Wissmiller | Direktor | 15. Mai 2026 A | 41.667 | 0 | 0 | $0 |
| Katie May | Direktor | 15. Mai 2026 A | 14.266 | 0 | 0 | $0 |
| Steven J. Fasching | Direktor | 15. Mai 2026 A | 15.369 | 0 | 0 | $0 |
| Robert D. Straus | Direktor | 15. Mai 2026 A | 56.514 | 0 | 0 | $0 |
| John Christopher Teets | Direktor | 6. Mai 2024 A | 55.315 | 0 | 0 | $0 |
| Richard D Moss | Direktor | 6. Mai 2024 A | 38.629 | 0 | 0 | $0 |
| Shirley Wu | Direktor | 4. Mai 2022 A | 9.149 | 0 | 0 | $0 |
| Mary Beth Springer | Direktor | 4. Mai 2022 A | 48.352 | 0 | 0 | $0 |
| Tariq Hassan | Direktor | 1. Juli 2021 A | 3.119 | 0 | 0 | $0 |
| Lily Zou | Direktor | 5. Mai 2021 A | 12.394 | 0 | 0 | $0 |
| Robert B Mercer | Direktor | 5. Mai 2021 A | 60.688 | 0 | 0 | $0 |
| Hongfei Jia | Direktor | 8. Mai 2019 A | 18.035 | 0 | 0 | $0 |
| Rebecca Lee Steinfort | Direktor | 9. Mai 2017 A | 15.022 | 0 | 0 | $0 |
| Albert R Dowden | Direktor | 9. Mai 2017 A | 27.221 | 0 | 0 | $0 |
| Eugene L Hughes | Direktor | 7. Mai 2014 A | 20.064 | 0 | 0 | $0 |
| Mark R Genender | Direktor | 1. August 2012 A | 3.076 | 0 | 0 | $0 |
| Pauline Hughes | Direktor | 17. August 2010 G | 320.120 | 0 | 0 | $0 |
| Candace K Weir | Direktor | 15. Juni 2010 S | 1.387.100 | 0 | 0 | $0 |
| Richard G Hinckley | Direktor | 15. Februar 2005 S | 0 | 0 | 0 | $0 |
| Franz L Cristiani | Direktor | 28. Mai 2004 A | · | 0 | 0 | $0 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 10%-Eigentümer | 15. Oktober 2024 S | 64.167 | 0 | 0 | $0 |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10%-Eigentümer | 4. Juni 2020 S | 1.499.404 | 0 | 0 | $0 |
| Jeffrey D Watkins | · | 6. Mai 2020 A | 44.915 | 0 | 0 | $0 |
| Kristine F Hughes | · | 11. November 2019 S | 74.062 | 0 | 0 | $0 |
| Gregory Probert | · | 12. Februar 2018 A | 231.305 | 0 | 0 | $0 |
| Paul Noack | · | 15. Januar 2017 F | 60.278 | 0 | 0 | $0 |
| Stephen M Bunker | · | 31. Mai 2016 P | 31.839 | 0 | 0 | $0 |
| David Wynne Roberts | · | 2. März 2015 F | 31.974 | 0 | 0 | $0 |
| Greg Halliday | · | 6. November 2009 A | · | 0 | 0 | $0 |
| John R Dewyze | · | 6. November 2009 A | 2.150 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 29 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 20.737 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,05% | 49.992 SH | 11. September 2026 | Täglich |
| ROSC · Lattice Strategies Trust | 0,04% | 1.232 NS | 31. Juli 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,04% | 240 NS | 31. Juli 2026 | N-PORT |
| VDC · VANGUARD WORLD FUND | 0,04% | 166.342 SH | 19. August 2026 | Täglich |
| DFAT · Dimensional ETF Trust | 0,01% | 105.125 NS | 31. Juli 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2.188 SH | 1. Oktober 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 85.033 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 9.327 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 4.374 SH | 19. August 2026 | Täglich |
| DFSV · Dimensional ETF Trust | 0,01% | 40.429 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 7.025 NS | 31. Juli 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,01% | 11.219 SH | 29. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 58.356 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 384.548 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 12.905 SH | 29. September 2026 | Täglich |
| IWO · iShares Trust | 0,00% | 37.258 SH | 11. September 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,00% | 1.930 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 30.081 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 3.780 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.023 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 2.512 NS | 31. Juli 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 1.029 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 24 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 169.599 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 421.191 SH | 19. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,00% | 2.188 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1.345 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 97.556 SH | 11. September 2026 | Täglich |
NATR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 8 Analysten
KAUF
Median-Ziel
$30.50
+145,0%
2 25,0%
Starker Kauf
5 62,5%
Kauf
1 12,5%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
2 Analysten · 2026-10-02Mittelwert-Ziel $30.50 +145,0%
← Unter allen Zielen
Aktueller Preis $12.45
Tief$25.00
Mittelwert$30.50
Hoch$36.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| NATR | $378M | 20.4 | 5.7% | 4.1% | 12.0% | 72.4% |
| USNA | $355M | 33.5 | 8.3% | 1.2% | 2.0% | 78.3% |
| NUS | · | 3.0 | -14.3% | 10.8% | 22.0% | 69.5% |
| NAGE | $507M | 31.8 | 29.9% | 13.4% | 24.7% | 64.3% |
| MED | $117M | -6.3 | -36.0% | -4.8% | -9.0% | 71.3% |
| UPXI | $62M | -0.2 | 58.1% | -984.3% | 9654.9% | 89.5% |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026